IL-25 Exacerbates Autoimmune Aortitis in IL-1 Receptor Antagonist-deficient Mice

Overview

Journal Sci Rep

Specialty Science

Date 2019 Nov 21

PMID 31745167

Citations 4

Authors

Takamichi Yoshizaki

Satoshi Itoh

Sachiko Yamaguchi

Takafumi Numata

Aya Nambu

Naoyuki Kimura

Hajime Suto

Ko Okumura

Katsuko Sudo

Atsushi Yamaguchi

Susumu Nakae

Affiliations

Soon will be listed here.

Abstract

IL-25, a member of the IL-17 family of cytokines, is known to enhance type 2 immune responses, but suppress type 3 (IL-17A)-mediated immune responses. Mice deficient in IL-1 receptor antagonist (Il1rn mice) have excessive IL-1 signaling, resulting in spontaneous development of IL-1-, TNF- and IL-17A-dependent aortitis. We found that expression of II25 mRNA was increased in the aortae of Il1rn mice, suggesting that IL-25 may suppress development of IL-1-, TNF- and IL-17A-dependent aortitis in Il1rn mice by inhibiting type 3-mediated immune responses. However, we unexpectedly found that Il25Il1rn mice showed attenuated development of aortitis, accompanied by reduced accumulation of inflammatory cells such as dendritic cells, macrophages and neutrophils and reduced mRNA expression of Il17a and Tnfa-but not Il4 or Il13-in local lesions compared with Il1rn mice. Tissue-, but not immune cell-, derived IL-25 was crucial for development of aortitis. IL-25 enhanced IL-1β and TNF production by IL-25 receptor-expressing dendritic cells and macrophages, respectively, at inflammatory sites of aortae of Il1rn mice, contributing to exacerbation of development of IL-1-, TNF- and IL-17A-dependent aortitis in those mice. Our findings suggest that neutralization of IL-25 may be a potential therapeutic target for aortitis.

Citing Articles

Current Insights into Tissue Injury of Giant Cell Arteritis: From Acute Inflammatory Responses towards Inappropriate Tissue Remodeling.

Palamidas D, Chatzis L, Papadaki M, Gissis I, Kambas K, Andreakos E Cells. 2024; 13(5.

PMID: 38474394 PMC: 10930978. DOI: 10.3390/cells13050430.

[F]FDG PET-MR characterization of aortitis in the IL1rn mouse model of giant-cell arteritis.

Deshayes S, Bauge C, Dupont P, Simard C, Rida H, de Boysson H EJNMMI Res. 2023; 13(1):103.

PMID: 38019303 PMC: 10687326. DOI: 10.1186/s13550-023-01039-5.

Animal models for large vessel vasculitis - The unmet need.

Chu C Rheumatol Immunol Res. 2023; 4(1):4-10.

PMID: 37138652 PMC: 10150876. DOI: 10.2478/rir-2023-0002.

Biomarkers Associated with Immune-Related Adverse Events under Checkpoint Inhibitors in Metastatic Melanoma.

Wolffer M, Battke F, Schulze M, Feldhahn M, Flatz L, Martus P Cancers (Basel). 2022; 14(2).

PMID: 35053465 PMC: 8773840. DOI: 10.3390/cancers14020302.

References

Veldhoen M, Hocking R, Atkins C, Locksley R, Stockinger B . TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 2006; 24(2):179-89. DOI: 10.1016/j.immuni.2006.01.001. View

Ohigashi H, Tamura N, Ebana Y, Harigai M, Maejima Y, Ashikaga T . Effects of immunosuppressive and biological agents on refractory Takayasu arteritis patients unresponsive to glucocorticoid treatment. J Cardiol. 2016; 69(5):774-778. DOI: 10.1016/j.jjcc.2016.07.009. View

Alvarez-Rodriguez L, Carrasco-Marin E, Lopez-Hoyos M, Mata C, Fernandez-Prieto L, Ruiz-Soto M . Interleukin-1RN gene polymorphisms in elderly patients with rheumatic inflammatory chronic conditions: Association of IL-1RN*2/2 genotype with polymyalgia rheumatica. Hum Immunol. 2008; 70(1):49-54. DOI: 10.1016/j.humimm.2008.10.011. View

Hernandez-Rodriguez J, Segarra M, Vilardell C, Sanchez M, Garcia-Martinez A, Esteban M . Tissue production of pro-inflammatory cytokines (IL-1beta, TNFalpha and IL-6) correlates with the intensity of the systemic inflammatory response and with corticosteroid requirements in giant-cell arteritis. Rheumatology (Oxford). 2003; 43(3):294-301. DOI: 10.1093/rheumatology/keh058. View

Comarmond C, Plaisier E, Dahan K, Mirault T, Emmerich J, Amoura Z . Anti TNF-α in refractory Takayasu's arteritis: cases series and review of the literature. Autoimmun Rev. 2011; 11(9):678-84. DOI: 10.1016/j.autrev.2011.11.025. View

Ishigame H, Nakajima A, Saijo S, Komiyama Y, Nambu A, Matsuki T . The role of TNFalpha and IL-17 in the development of excess IL-1 signaling-induced inflammatory diseases in IL-1 receptor antagonist-deficient mice. Ernst Schering Res Found Workshop. 2005; (56):129-53. DOI: 10.1007/3-540-37673-9_8. View

Wang W, Li Y, Lv Z, Chen Y, Li Y, Huang K . Bronchial Allergen Challenge of Patients with Atopic Asthma Triggers an Alarmin (IL-33, TSLP, and IL-25) Response in the Airways Epithelium and Submucosa. J Immunol. 2018; 201(8):2221-2231. DOI: 10.4049/jimmunol.1800709. View

Nakanishi W, Yamaguchi S, Matsuda A, Suzukawa M, Shibui A, Nambu A . IL-33, but not IL-25, is crucial for the development of house dust mite antigen-induced allergic rhinitis. PLoS One. 2013; 8(10):e78099. PMC: 3808342. DOI: 10.1371/journal.pone.0078099. View

Matsuki T, Isoda K, Horai R, Nakajima A, Aizawa Y, Suzuki K . Involvement of tumor necrosis factor-alpha in the development of T cell-dependent aortitis in interleukin-1 receptor antagonist-deficient mice. Circulation. 2005; 112(9):1323-31. DOI: 10.1161/CIRCULATIONAHA.105.564658. View

10.

Mukhtyar C, Guillevin L, Cid M, Dasgupta B, de Groot K, Gross W . EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis. 2008; 68(3):318-23. DOI: 10.1136/ard.2008.088351. View

11.

Stone J, Bruneval P, Angelini A, Bartoloni G, Basso C, Batoroeva L . Consensus statement on surgical pathology of the aorta from the Society for Cardiovascular Pathology and the Association for European Cardiovascular Pathology: I. Inflammatory diseases. Cardiovasc Pathol. 2015; 24(5):267-78. DOI: 10.1016/j.carpath.2015.05.001. View

12.

Hoffman G, Leavitt R, Kerr G, Rottem M, Sneller M, Fauci A . Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate. Arthritis Rheum. 1994; 37(4):578-82. DOI: 10.1002/art.1780370420. View

13.

Paul W, Zhu J . How are T(H)2-type immune responses initiated and amplified?. Nat Rev Immunol. 2010; 10(4):225-35. PMC: 3496776. DOI: 10.1038/nri2735. View

14.

Noris M . Pathogenesis of Takayasu's arteritis. J Nephrol. 2002; 14(6):506-13. View

15.

Nicklin M, Hughes D, Barton J, Ure J, Duff G . Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene. J Exp Med. 2000; 191(2):303-12. PMC: 2195758. DOI: 10.1084/jem.191.2.303. View

16.

Schneider C, OLeary C, Locksley R . Regulation of immune responses by tuft cells. Nat Rev Immunol. 2019; 19(9):584-593. PMC: 8331098. DOI: 10.1038/s41577-019-0176-x. View

17.

Shepherd J, Nicklin M . Elastic-vessel arteritis in interleukin-1 receptor antagonist-deficient mice involves effector Th1 cells and requires interleukin-1 receptor. Circulation. 2005; 111(23):3135-40. DOI: 10.1161/CIRCULATIONAHA.104.519132. View

18.

Sonobe Y, Takeuchi H, Kataoka K, Li H, Jin S, Mimuro M . Interleukin-25 expressed by brain capillary endothelial cells maintains blood-brain barrier function in a protein kinase Cepsilon-dependent manner. J Biol Chem. 2009; 284(46):31834-42. PMC: 2797254. DOI: 10.1074/jbc.M109.025940. View

19.

Angkasekwinai P, Park H, Wang Y, Wang Y, Chang S, Corry D . Interleukin 25 promotes the initiation of proallergic type 2 responses. J Exp Med. 2007; 204(7):1509-17. PMC: 2118650. DOI: 10.1084/jem.20061675. View

20.

Van Dyken S, Mohapatra A, Nussbaum J, Molofsky A, Thornton E, Ziegler S . Chitin activates parallel immune modules that direct distinct inflammatory responses via innate lymphoid type 2 and γδ T cells. Immunity. 2014; 40(3):414-24. PMC: 4019510. DOI: 10.1016/j.immuni.2014.02.003. View